Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pugh

Showing results (351-360 of 602) with videos related to

Pageof 61
Sort By:
Brachytherapy|May 15, 2017
Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markersGeoffrey V Martin, Thomas J Pugh, Usama Mahmood, et al.
Annals of Surgery|October 16, 2020
Transplant Oncology in Primary and Metastatic Liver Tumors: Principles, Evidence, and OpportunitiesGonzalo Sapisochin, Taizo Hibi, Christian Toso, et al.
Cold Spring Harbor Molecular Case Studies|January 13, 2023
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progressionDanielle C Croucher, Anup Joseph Devasia, Dor D Abelman, et al.
Brachytherapy|April 27, 2017
Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancerMatthew W Jackson, Arya Amini, Bernard L Jones, et al.
Clinical Genetics|September 17, 2013
A systematic approach to assessing the clinical significance of genetic variantsH Duzkale, J Shen, H McLaughlin, et al.
Endocrine Research|January 26, 2006
Physiologic testosterone therapy has no effect on serum levels of tumour necrosis factor-alpha in men with chronic heart failurePeter J Pugh, Richard D Jones, Chris J Malkin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Comprehensive molecular assessment of mismatch repair deficiency in Lynch associated ovarian cancers using next generation sequencing panelSoyoun Rachel Kim, Leslie Oldfield, Alicia Tone, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 11, 2013
Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errorsThomas J Pugh, Richard A Amos, Sandra John Baptiste, et al.
Journal of Contemporary Brachytherapy|August 10, 2016
Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experienceTze Yee Lim, Rajat J Kudchadker, Jihong Wang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 8, 2023
Comprehensive molecular assessment of mismatch repair deficiency in Lynch associated ovarian cancers using next generation sequencing panelSoyoun Rachel Kim, Leslie Oldfield, Alicia Tone, et al.
Pageof 61

Showing results (351-360 of 602) with videos related to

Sort By:
Pageof 61
Brachytherapy|May 15, 2017
Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markersGeoffrey V Martin, Thomas J Pugh, Usama Mahmood, et al.
Annals of Surgery|October 16, 2020
Transplant Oncology in Primary and Metastatic Liver Tumors: Principles, Evidence, and OpportunitiesGonzalo Sapisochin, Taizo Hibi, Christian Toso, et al.
Cold Spring Harbor Molecular Case Studies|January 13, 2023
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progressionDanielle C Croucher, Anup Joseph Devasia, Dor D Abelman, et al.
Brachytherapy|April 27, 2017
Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancerMatthew W Jackson, Arya Amini, Bernard L Jones, et al.
Clinical Genetics|September 17, 2013
A systematic approach to assessing the clinical significance of genetic variantsH Duzkale, J Shen, H McLaughlin, et al.
Endocrine Research|January 26, 2006
Physiologic testosterone therapy has no effect on serum levels of tumour necrosis factor-alpha in men with chronic heart failurePeter J Pugh, Richard D Jones, Chris J Malkin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Comprehensive molecular assessment of mismatch repair deficiency in Lynch associated ovarian cancers using next generation sequencing panelSoyoun Rachel Kim, Leslie Oldfield, Alicia Tone, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 11, 2013
Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errorsThomas J Pugh, Richard A Amos, Sandra John Baptiste, et al.
Journal of Contemporary Brachytherapy|August 10, 2016
Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experienceTze Yee Lim, Rajat J Kudchadker, Jihong Wang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 8, 2023
Comprehensive molecular assessment of mismatch repair deficiency in Lynch associated ovarian cancers using next generation sequencing panelSoyoun Rachel Kim, Leslie Oldfield, Alicia Tone, et al.
Pageof 61